SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Tularik Inc. (TLRK)
An SI Board Since October 1999
Posts SubjectMarks Bans Symbol
598 27 0 TLRK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
548This constitutes a handy beating of earnings and revenue estimates -- but the matuck-1/29/2004
547LIZ CLAMAN, CNBC ANCHOR: From liver cancer to obesity and diabetes, Tularik imopgcw-1/18/2004
546not certain, but believe that I just heard a tickler that Goeddel will be on CNBscaram(o)uche-1/13/2004
545>> T71 is an orally-active, new chemical entity that was shown in precliniscaram(o)uche-1/12/2004
544Tularik to Provide Clinical Development Update and 2004 Financial Guidance at JPscaram(o)uche-1/12/2004
543Tularik Initiates Phase 2 Clinical Trial of T131 in Type 2 Diabetes Wednesday Jascaram(o)uche-1/7/2004
542there appears to be some open contracts out to jul '04.. up to $20 strike fomopgcw-1/6/2004
541I know. I was looking to sell some covered calls here and nada. strange...mopgcw-1/5/2004
540Let's hope there's some liquidity in these. Tularik has had options tratuck-1/5/2004
539Pacific Exchange to Trade 12 New Options 2003-12-23 16:43 (New York) SAN Fmopgcw-1/5/2004
538>> one can't be out of this stock << clear, good call! thanks!scaram(o)uche-12/12/2003
537Tularik Initiates Phase 2 Clinical Trial of T487 in Psoriasis Wednesday Decemberscaram(o)uche-12/10/2003
536Tularik and Sankyo Advance GPCR Drug Discovery Collaboration Tuesday December 9,scaram(o)uche-12/9/2003
535Just following ChemoCentryx...... Virology. 2003 Nov 25;316(2):202-212. A mascaram(o)uche-12/4/2003
534Tularik Earns Milestone Payment from Eli Lilly and Company Thursday December 4, nigel bates-12/4/2003
533platinum asset management owns 4.75% of tlrk now.mopgcw-11/19/2003
532Wouldn't it be cool if Amgen continued to make private buys? Well, the reposcaram(o)uche-11/17/2003
531Tularik, Maker of Cancer Treatments, Raises $71.4 Million 2003-11-10 18:56 (New mopgcw-11/10/2003
530Tularik Announces Public Offering of Common Stock Tuesday November 4, 7:42 am ETnigel bates-11/4/2003
529Cumbre Inc. and University of Wisconsin-Madison Research Collaborator Publish Danigel bates-10/23/2003
528Oct 22 2003 8:09AM ** Tularik receives FDA fast-track for T67 (TLRK) 11.98: BJim Oravetz-10/22/2003
527Only mention I have heard is by way of exclusion. It is a CNS target, but it keokalani'nui-10/20/2003
526TLRK CC part 2: David Witzke, SunTrust - Analyst [8] -----------------------mopgcw-10/19/2003
525Final Event Transcript of TLRK conference call, 16-Oct-03 4:30pm 2003-10-17 16:1mopgcw-10/19/2003
524Based on patent application (only one for this field, so far)it is MCHr1 antagonMiljenko Zuanic-10/19/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News